Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
6.49K
-
Shares change
-
+1.89K
-
Total reported value, excl. options
-
$308K
-
Value change
-
+$104K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$47.47
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2023
2 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q4 2023.
IRADIMED CORP - Common Stock (IRMD) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.49K shares
of 12.7M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (799K shares), BlackRock Inc. (652K shares), Soleus Capital Management, L.P. (643K shares), RENAISSANCE TECHNOLOGIES LLC (580K shares), VANGUARD GROUP INC (427K shares), RK Capital Management, LLC (340K shares), Bares Capital Management, Inc. (277K shares), Ranger Investment Management, L.P. (224K shares), Russell Investments Group, Ltd. (211K shares), and DIMENSIONAL FUND ADVISORS LP (211K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.